Sign In
test

Jason Mehar

Royalty Pharma Sub-manager, Llc

Assets Managed
$172.764M
Holdings
4
Last Quarter
2026 - Q1
Filed Date
12d ago
Growth Rate
0.85%(2Q avg: 0.43%)
Sustained Growth
1 quarters

Portfolio positions

This chart displays the top 10 holdings in Royalty Pharma Sub-manager, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 4 positions.

Assets under management

The assets under management (AUM) of Royalty Pharma Sub-manager, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 172.764M in assets, with a quarterly growth rate of 0.85% and a 2-quarter average growth rate of 0.43%. The portfolio is managed by Jason Mehar, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
CYTK
Cytokinetics Inc
Recent Activity
37.41%
$64.618M
980,392 shares@ $65.92 avg price
BCAX
Bicara Therapeutics Inc
Recent Activity
Increased 89.07%
27.03%
$46.688M
2.388M shares@ $19.56 avg price
BCRX
Biocryst Pharmaceuticals Inc
Recent Activity
21.2%
$36.615M
3.846M shares@ $9.52 avg price
BHVN
Biohaven Ltd
Recent Activity
14.38%
$24.843M
2.937M shares@ $8.46 avg price

1-4 of 4